Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Malignant Melanoma

Free Subscription Articles published in J Clin Invest Retrieve available abstracts of 16 articles: HTML format Text format

Single Articles

January 2010
1. DERRE L , Rivals JP, Jandus C, Pastor S, et al
   BTLA mediates inhibition of human tumor-specific CD8+ T cells that can be partially reversed by vaccination.
   J Clin Invest. 2010;120:157-67.
   PubMed     Text format     Related articles    Abstract available
   
   
   September 2009
2. SOMAN NR , Baldwin SL, Hu G, Marsh JN, et al
   Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth.
   J Clin Invest. 2009;119:2830-42.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. DARRASSE-JEZE G , Bergot AS, Durgeau A, Billiard F, et al
   Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.
   J Clin Invest. 2009;119:2648-62.
   PubMed     Text format     Related articles    Abstract available
   
   
   August 2009
4. ZITVOGEL L , Kroemer G
   Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects.
   J Clin Invest. 2009;119:2127-30.
   PubMed     Text format     Related articles    Abstract available
   
   
   July 2009
5. BESCH R , Poeck H, Hohenauer T, Senft D, et al
   Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells.
   J Clin Invest. 2009 Jul 20. pii: 37155. doi: 10.1172/JCI37155.
   PubMed     Text format     Related articles    Abstract available
   
   
   April 2009
6. LAKSHMIKANTH T , Burke S, Ali TH, Kimpfler S, et al
   NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
   J Clin Invest. 2009 Apr 6. pii: 36022. doi: 10.1172/JCI36022.
   PubMed     Text format     Related articles    Abstract available
   
   
   March 2009
7. PASSERON T , Valencia JC, Namiki T, Vieira WD, et al
   Upregulation of SOX9 inhibits the growth of human and mouse melanomas and restores their sensitivity to retinoic acid.
   J Clin Invest. 2009 Mar 9. pii: 34015. doi: 10.1172/JCI34015.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2008
8. SKOBERNE M , Yewdall A, Bahjat KS, Godefroy E, et al
   KBMA Listeria monocytogenes is an effective vector for DC-mediated induction of antitumor immunity.
   J Clin Invest. 2008;118:3990-4001.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2008
9. HENDRICKSON AW , Meng XW, Kaufmann SH
   Anticancer therapy: boosting the bang of Bim.
   J Clin Invest. 2008;118:3582-4.
   PubMed     Text format     Related articles    Abstract available
   
   
   October 2008
10. BEDOGNI B , Warneke JA, Nickoloff BJ, Giaccia AJ, et al
    Notch1 is an effector of Akt and hypoxia in melanoma development.
    J Clin Invest. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. KUJAWSKI M , Kortylewski M, Lee H, Herrmann A, et al
    Stat3 mediates myeloid cell-dependent tumor angiogenesis in mice.
    J Clin Invest. 2008;118:3367-77.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2008
12. SANCHO D , Mourao-Sa D, Joffre OP, Schulz O, et al
    Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin.
    J Clin Invest. 2008;118:2098-110.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2008
13. STIRNEMANN K , Romero JF, Baldi L, Robert B, et al
    Sustained activation and tumor targeting of NKT cells using a CD1d-anti-HER2-scFv fusion protein induce antitumor effects in mice.
    J Clin Invest. 2008;118:994-1005.
    PubMed     Text format     Related articles    Abstract available   Free Full Text
    
    
    
14. LIU C , Lou Y, Lizee G, Qin H, et al
    Plasmacytoid dendritic cells induce NK cell-dependent, tumor antigen-specific T cell cross-priming and tumor regression in mice.
    J Clin Invest. 2008;118:1165-75.
    PubMed     Text format     Related articles    Abstract available   Free Full Text
    
    
    January 2008
15. AIKAWA T , Whipple CA, Lopez ME, Gunn J, et al
    Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells.
    J Clin Invest. 2008;118:89-99.
    PubMed     Text format     Related articles    Abstract available   Free Full Text
    
    
    November 2007
16. ZHOU D
    OX40 signaling directly triggers the antitumor effects of NKT cells.
    J Clin Invest. 2007;117:3169-72.
    PubMed     Text format     Related articles    Abstract available   Free Full Text
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: